The trademark application Ofloxa-Vision was filed by OmniVision GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on August 14, 2016, and it was registered by office on November 21, 2016 without any oppositions.
The application was filed in German (English was selected as the second language).
A transfer of the trademark registration was recorded on December 23, 2018. Change of name and address of the trademark registration was recorded on February 28, 2019.